Intestinal Ischemia and Infarction Pathology

Vascular Compromise and Hypoperfusion

• Arterial occlusion (thromboembolism, atherosclerotic stenosis) or venous thrombosis creates immediate reduction in oxygen delivery below tissue metabolic demands
• Intestinal tissues have high metabolic rates; the splanchnic circulation normally receives 25% of cardiac output, and ischemia develops when perfusion pressure drops below 40-50 mmHg
• The mucosa and submucosa are most vulnerable (watershed zones), while the muscularis propria and serosa show greater ischemic tolerance due to lower metabolic demands

Reperfusion Injury and Mucosal Barrier Dysfunction

• Initial ischemic phase causes cellular ATP depletion, loss of Na+/K+-ATPase function, and cytoplasmic edema with cell swelling
• Restoration of blood flow paradoxically amplifies injury through reactive oxygen species (ROS) generation, particularly via xanthine oxidase activation and mitochondrial dysfunction
• Hypoxia-inducible factor (HIF) stabilization during ischemia triggers inflammatory cascade; reoxygenation causes HIF degradation and inflammatory amplification
• Loss of tight junction integrity (claudins, occludin, ZO-1) permits bacterial translocation and lipopolysaccharide (LPS) translocation, triggering systemic inflammation

Inflammatory Cascade and Leukocyte Infiltration

• Toll-like receptor (TLR) signaling and NF-κB activation in intestinal epithelial and endothelial cells
• Pro-inflammatory cytokine release (TNF-α, IL-6, IL-8) recruits neutrophils and macrophages; myeloperoxidase (MPO) activity drives additional oxidative stress
• Complement activation via both classic and alternative pathways amplifies endothelial injury
• Microvascular no-reflow phenomenon: leukocyte plugging and endothelial cell swelling cause capillary occlusion despite restored macrovascular flow

Morphological Progression

• Phase 1 (0-6 hours)—Mucosal edema: Loss of goblet cells, intestinal gland dilation, hemorrhagic infiltration without necrosis
• Phase 2 (6-24 hours)—Transmural involvement: Coagulative necrosis of mucosa and submucosa with ghost cells (karyorrhectic nuclei), hemorrhage, bacterial overgrowth
• Phase 3 (>24 hours)—Full-thickness infarction: Transmural necrosis with loss of muscularis propria architecture, fibrinous necrosis, abscess formation, and perforation

Acute Arterial Occlusion (most common; ~50% of acute mesenteric ischemia)

• Arterial thromboembolism: Cardioemboli (atrial fibrillation, recent MI, dilated cardiomyopathy) lodge at SMA origin or bifurcations; thrombosis occurs in situ on atherosclerotic plaques
• Atherosclerotic stenosis with thrombosis: Progressive atherosclerotic disease at aortic origin of SMA/celiac axis; acute thrombosis typically occurs at >70% stenosis
• Aortic dissection: Compromises SMA origin; typically Type A dissection extending into visceral vessels

Acute Venous Thrombosis (~10-15% of acute mesenteric ischemia)

• Portal or mesenteric vein thrombosis: Associated with hypercoagulable states (malignancy, protein C/S deficiency, antithrombin III deficiency, Factor V Leiden), cirrhosis, IBD, recent abdominal surgery, portal vein catheterization
• Slower progression allows some collateral development, resulting in lower mortality than arterial disease

Non-Occlusive Ischemia (20-30% of acute mesenteric ischemia; poor prognosis)

• Low-flow states: Cardiogenic shock, sepsis, severe dehydration causing splanchnic vasoconstriction despite patent vessels
• Vasoconstrictive medications: Vasopressin, high-dose catecholamines causing alpha-adrenergic vasoconstriction
• Mechanics of injury: Intestinal hypoperfusion without occlusion; reperfusion with therapeutic interventions causes amplified ischemic-reperfusion injury

Chronic Mesenteric Ischemia

• Atherosclerotic stenosis (>70%) of two or more mesenteric vessels; slow progression permits collateral development
• Risk factors: smoking, hypertension, hyperlipidemia, diabetes, advanced age

Focal Ischemia

• Strangulated hernia, volvulus, intussusception: Mechanical obstruction with vascular compromise
• Small bowel obstruction from adhesions causing localized mucosal ischemia

Inflammatory and Hypercoagulable States

• Inflammatory bowel disease (IBD): Increased thrombotic risk; mesenteric vasculitis
• Thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS): Microangiopathic thrombosis
• Behçet disease, systemic lupus erythematosus (SLE): Vasculitis with ischemic complications

Special Populations and Iatrogenic Causes

• Aortic aneurysm repair: Inadvertent IMA ligation (watershed area at Griffith point); interruption of Sudeck point collaterals
• Cocaine use: Intense vasoconstriction of mesenteric vessels
• Digitalis toxicity: Direct vasoconstrictive effects on splanchnic circulation

Cardinal Symptom: "Pain Out of Proportion to Physical Examination"

• Acute severe abdominal pain (sudden onset in arterial occlusion; gradual in venous thrombosis) that is colicky initially then becomes diffuse and constant
• Pain results from both mucosal ischemia and full-thickness transmural involvement with peritoneal irritation
• Early stage: pain precedes physical findings because visceral innervation (unmyelinated C-fibers) conveys pain despite minimal mucosal changes
• Morphological correlate: pain intensity increases as ischemic zone expands from mucosa through submucosa to muscularis

Gastrointestinal Symptoms

• Diarrhea (often bloody): Due to mucosal erosion and sloughing; appears within first 12-24 hours in acute arterial disease
• Nausea and vomiting: From intestinal dysmotility and reflex responses to visceral pain
• Abdominal distension: Reflects loss of peristalsis and adynamic ileus as muscularis propria becomes involved
• Hematochezia or melena: Indicates mucosal breakdown with hemorrhage; more common in venous thrombosis due to slower progression

Physical Examination Findings (Evolving with Severity)

• Early (<6 hours): Mild abdominal tenderness, minimal peritoneal signs; examination may be deceptively benign
• Rebound tenderness and guarding: Develops with transmural involvement and peritoneal irritation (phase 2-3); indicates full-thickness necrosis
• Abdominal distension and hypoactive/absent bowel sounds: Reflect ileus and loss of muscle function
• Shock state (late finding): Tachycardia, hypotension, altered mental status from bacterial translocation, endotoxemia, and septic shock
• Palpable abdominal mass: Occasionally noted with thrombosed mesenteric vessels or localized infarction

Systemic Manifestations

• Metabolic acidosis: From anaerobic metabolism in ischemic tissue; elevated serum lactate (>4 mmol/L suggests transmural necrosis)
• Fever and leukocytosis: From mucosal barrier breakdown, bacterial translocation, and systemic inflammatory response

Clinical Suspicion and Laboratory Evaluation

Serum Biomarkers

• Elevated serum lactate (>2 mmol/L suggests tissue hypoperfusion): Non-specific but sensitive; levels >4 mmol/L indicate transmural involvement
• Elevated D-dimer and prothrombin time (PT): Reflect activation of coagulation cascade; particularly elevated in venous thrombosis
• Leukocytosis (WBC >11,000/μL): Non-specific inflammatory response; extreme elevation (>15,000) suggests advanced disease
• Elevated amylase and lipase: May be present but non-specific; reflects pancreatic ischemia in extensive SMA territory involvement
• Phosphate and potassium derangements: From cellular necrosis and release of intracellular contents

Imaging Studies (Critical for Diagnosis)

CT Angiography (CTA) of Abdomen and Pelvis with IV Contrast

• Gold standard imaging modality for diagnosis
• Acute arterial occlusion findings: Abrupt SMA/IMA cutoff with embolic appearance (convex occlusion at branching point); high attenuation thrombus; mesenteric artery wall calcification in chronic stenosis
• Venous thrombosis findings: Direct visualization of low-attenuation thrombus within portal or mesenteric veins; portosystemic collaterals may develop
• Bowel wall changes: Segmental bowel wall thinning (<3 mm, indicates necrosis), wall thickening (edema, early phase), thumbprinting (mucosal edema pattern), pneumatosis intestinalis (air within bowel wall—pathognomonic for transmural necrosis)
• Other CTA signs: Mesenteric fat stranding, ascites (hemorrhagic if necrosis present), lack of bowel enhancement (indicates necrosis)

Duplex Ultrasound

• Non-invasive initial screening in stable patients; limited by operator dependence and obesity
• Shows absence of arterial flow signals in mesenteric vessels
• Useful for chronic mesenteric ischemia surveillance

Abdominal Plain Films (Limited Diagnostic Value)

• May show pneumoperitoneum (indicates perforation with transmural necrosis)
• Pneumatosis intestinalis: Pathognomonic when present; appears as linear or bubbly lucencies in bowel wall
• Portal venous gas: Ominous sign indicating extensive mucosal necrosis with gas-forming organisms
• Findings indicate advanced disease requiring emergent intervention

Colonoscopy/Endoscopy

• Reserved for cases where diagnosis remains unclear or to assess viability in partial thickness ischemia
• Shows patchy mucosal ulceration, dark red discoloration, loss of haustral pattern in colon
• Can assess extent of injury but does not reliably predict transmural involvement

Histological Findings (Gold Standard for Confirmation)

• Acute Phase (0-6 hours):
• Mucosal edema with preservation of glandular architecture
• Superficial hemorrhagic infiltration in lamina propria
• Capillary ectasia and congestion
• Intact epithelium (though may show early loss of goblet cells)

• Early Necrotic Phase (6-24 hours):
• Coagulative necrosis affecting mucosa and submucosa
• Ghost cells: Ischemic myocytes and epithelial cells with pyknotic nuclei and preserved cytoplasmic outline
• Loss of cellular detail with karyorrhexis
• Hemorrhagic necrosis with extravasated RBCs
• Acute inflammatory infiltrate (neutrophils predominate)
• Muscularis propria may show early changes but retains architecture

• Transmural Infarction Phase (>24 hours):
• Full-thickness coagulative necrosis extending through all layers
• Fibrinous necrosis with fibrin deposition
• Loss of normal histological architecture (glands, muscle fibers unrecognizable)
• Prominent acute inflammation with abscess formation
• Bacterial overgrowth within necrotic tissue
• Grossly: Segmental dark purple/black discoloration of bowel

Gross Pathology

• Early (mucosal phase): Edematous, congested segment; mucosa may appear dark red with hemorrhagic streaking
• Established infarction: Dark purple to black discoloration of full thickness of bowel wall; segment becomes firm and leathery
• Demarcation line: Clear delineation between viable (pink/red) and necrotic (dark/black) bowel, typically following vascular distribution
• Perforation findings: Transmural necrosis with breach in serosa; fibrinopurulent peritonitis if perforated
• Vascular examination: May visualize thrombus within mesenteric arteries or veins; atherosclerotic plaques at vessel origin

Diagnostic Criteria for Intestinal Infarction

• Acute onset of abdominal pain with systemic toxicity
• Imaging evidence of vascular occlusion OR bowel wall necrosis
• Histological confirmation of coagulative necrosis
• Prognosis worsens with delay in diagnosis (mortality increases from ~30% if diagnosed <24 hours to >60% if >24 hours)

First-Line Management: Emergent Vascular Intervention

Arterial Revascularization (for Acute Arterial Occlusion)

• Percutaneous catheter-directed thrombolysis/thrombectomy: First-line intervention in many centers for acute SMA thromboembolism
• Rationale: Restores perfusion while preserving viable bowel; avoids open surgery in unstable patients
• Technique: Selective SMA catheterization followed by mechanical thrombectomy or infusion of tissue plasminogen activator (tPA)
• Success rates: 50-80% if instituted within 12-24 hours
• Advantage: Allows assessment of bowel viability before open intervention

• Open surgical thromboembolectomy: Indicated if catheter intervention fails, contraindicated, or patient unstable requiring immediate decompression
• Technique: Transverse arteriotomy over occlusion site with Fogarty catheter thrombectomy
• Allows intraoperative assessment of bowel viability using fluorescein dye and Wood's lamp or laser Doppler perfusion assessment

Venous Thrombosis Management

• Anticoagulation: Immediate IV unfractionated heparin followed by warfarin or DOAC for 3+ months
• Rationale: Unlike arterial disease, venous occlusion may resolve with anticoagulation alone; permits collateral development
• Catheter-directed thrombolysis: Consider if acute presentation (<7 days) with extensive thrombosis or signs of bowel compromise
• Thrombectomy: Reserved for cases with evident transmural necrosis or perforation despite anticoagulation

Non-Occlusive Ischemia

• Restoration of perfusion pressure: Aggressive fluid resuscitation, vasopressor withdrawal, treatment of underlying shock
• Selective mesenteric vasodilation: Intra-arterial papaverine infusion (40 mg/hour) or nitroglycerin to reverse vasospasm

Emergencies — act before imaging is complete

• Transmural infarction with perforation: full-thickness coagulative necrosis destroys the serosal barrier; signalled by rigid abdomen, free intraperitoneal air, or falling bowel-wall enhancement on CTA. Requires emergent laparotomy with resection of nonviable bowel — no vascular intervention alone will salvage necrotic gut.
• Septic shock from bacterial translocation: loss of tight-junction integrity allows enteric organisms and LPS into portal and systemic circulation; signalled by fever, refractory hypotension, and rising lactate despite fluids. Managed per the Surviving Sepsis Campaign with early broad-spectrum antibiotics and source control (resection).
• Portal venous gas and pneumatosis intestinalis: gas-forming organisms track through the necrotic wall into mesenteric/portal veins; on CT this combination is an ominous marker of transmural necrosis, not an incidental finding.
• Reperfusion syndrome after revascularization: washout of potassium, hydrogen ion, and inflammatory mediators from reperfused bowel produces hyperkalemia, lactic acidosis, arrhythmia, and acute kidney injury; monitor electrolytes and rhythm during and after restoration of flow.
• Abdominal compartment syndrome: bowel edema plus large-volume resuscitation raises intra-abdominal pressure; signalled by oliguria, rising peak airway pressures, and elevated bladder pressure — decompressive laparotomy is the treatment.
• Fulminant/gangrenous colitis with toxic megacolon: recognized by the ACG colon ischemia guideline as an indication for urgent surgery rather than continued medical management.

Later and treatment-related complications

• Ischemic stricture: submucosal fibrosis during healing narrows the watershed segment weeks to months later; presents as obstructive symptoms with a smooth tapered stenosis on contrast study or colonoscopy.
• Chronic segmental ischemic colitis: persistent bloody diarrhea and protein-losing enteropathy from a nonhealed segment.
• Short bowel syndrome: massive resection leaves inadequate absorptive surface; watery diarrhea, malabsorption, and dependence on parenteral nutrition (ASPEN guidance), with downstream catheter sepsis and intestinal failure–associated liver disease.
• Anastomotic leak: anastomosis constructed in marginally perfused bowel; this risk drives the planned second-look laparotomy strategy after initial resection.
• Therapy-specific risks: hemorrhage from catheter-directed thrombolysis, heparin-induced thrombocytopenia during anticoagulation, and recurrent embolism if the cardiac source (e.g., atrial fibrillation) is not anticoagulated per ACC/AHA/HRS recommendations.

• "Pain out of proportion to exam" in an elderly patient with atrial fibrillation: the stem is describing an SMA embolus. Emboli lodge just distal to the origin (often beyond the middle colic branch, sparing the proximal jejunum), whereas in-situ thrombosis on atherosclerotic plaque occludes the SMA ostium and infarcts a larger territory.
• Single best next step is CT angiography of the abdomen and pelvis (ACR Appropriateness Criteria). Do not delay for lactate, do not order oral contrast (it obscures mucosal enhancement), and do not withhold IV contrast over contrast-nephropathy fears in a patient with suspected acute mesenteric ischemia.
• A normal lactate does not exclude ischemia: lactate rises late, once necrosis is established. This is the most common distractor — a benign abdomen plus normal labs in the first hours is the classic deceptively reassuring presentation.
• Bowel infarcts are hemorrhagic (red) infarcts: the association examiners test is red infarction in organs with dual or collateral supply and loose tissue — bowel, lung, testis — versus pale infarcts in kidney, spleen, heart. Gross specimen: dusky purple-black segment with a sharp demarcation line.
• Watershed anatomy of ischemic colitis: splenic flexure (Griffiths point, SMA–IMA) and rectosigmoid junction (Sudeck point, IMA–hypogastric). The rectum is characteristically spared because of dual middle/inferior rectal supply from the internal iliac — rectal involvement should push you toward infection or IBD.
• Colonic ischemia is a different disease from acute mesenteric ischemia: per the ACG, most cases are nonocclusive, present with left-sided pain and bloody diarrhea, are diagnosed by colonoscopy (segmental erythema, single linear ulcer, colon single-stripe sign), and resolve with supportive care — angiography is usually unnecessary.
• Buzzwords to convert instantly: thumbprinting = submucosal edema/hemorrhage; pneumatosis intestinalis + portal venous gas = transmural necrosis, go to the OR; ghost cells with pyknotic nuclei = ischemic coagulative necrosis.
• Post-AAA-repair left colon ischemia follows IMA ligation; postprandial pain, food fear, and weight loss in a vasculopath is chronic mesenteric ischemia, and its distractor is occult malignancy.